Anis Miladi, MD; Brian C. Thomas, MD; Knox Beasley, MD; Jon Meyerle, MD
Dr. Miladi is from the Department of Dermatology, Naval Medical Center Portsmouth, Virginia. Dr. Thomas is from Tennessee River Dermatology, Florence, Alabama. Dr. Beasley is from William Beaumont Army Medical Center, El Paso, Texas. Dr. Meyerle is from Uniformed Services University of the Health Sciences, Bethesda.
The authors report no conflict of interest. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Army, Department of Defense, or the US Government. This case report was presented in part at the 69th Annual Meeting of the American Academy of Dermatology; February 4-8, 2011; New Orleans, Louisiana.
Correspondence: Anis Miladi, MD, Department of Dermatology, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708-2197 (anis.miladi@med.navy.mil).
The development of purpura fulminans and disseminated intravascular coagulation in a patient with AITL is rare. Although the exact mechanism for the thrombus formation in the skin has not been elucidated, purpura fulminans typically develops secondary to a severe infection. The exact incidence of purpura fulminans in the setting of AITL is unknown, but purpura as a cutaneous eruption has been associated as a clinical finding in AITL.6 Although our case may be a rare presentation of AITL, a prompt and accurate diagnosis can drastically change the prognosis of this aggressive disease.